Related Articles
Activation of activin/Smad2 and 3 signaling pathway and the potential involvement of endothelial‑mesenchymal transition in the valvular damage due to rheumatic heart disease
Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease
shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells
Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease
Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review)